Date & Time: Thursday, March 20, 2008. 12pm -1:30pm Mountain Time.
Faculty:
Suzanne Y. Pecoraro, RD, MPH, CDE. President of the Diabetes Education Society. Educator for Boulder Endocrinology. Past board member of American Association of Diabetes Educators. Past President of Rocky Mountain Association of Diabetes Educators.
Anne Ruelle, RN, CDE. Speaker for Eli Lilly’s DIN program and Abbott Diabetes. Consultant to TOPS-international weight loss program. Previously, Director of Diabetes and Lipid Management at Advanced Health Care-a merged group of 17 outpatient clincs, Milwaukee,Wisconsin.
Summary:
This program reviews blood glucose goals and the importance of glucose variability in long-range complications of diabetes. It also reviews new therapies available for diabetes management and their role in adjunct therapy. These new hormones represent tri-hormonal management of diabetes and prevention of complications. Case studies using these therapies are presented.
Objectives:
At the end of the presentation participants will be able to:
- Define blood glucose goals pre/post meals and HbA1C goals to prevent complications
- Discuss glucose variability and concern for long term complications.
- Identify factors related to effective use of point in time self-blood glucose monitoring.
- Discuss the use of new therapies (GLP-1, DPP-4) inhibitors and amylin replacement) as adjunct therapy for diabetes.
- Review cases and make recommendations for therapy changes
using advanced diabetes therapy and technology.
Outline:
| Blood glucose goals | ||
| Pre/post meal values | ||
| HbA1C goals | ||
| Glucose variability and concern for long term complications | ||
| Good A1C but blood glucose values have wide ranges | ||
| Evidence for concern about glucose variability and long term complications | ||
| Effective use of point in time testing technology | ||
| Data management options | ||
| Review glucose values to identify patterns | ||
| Use GLP-1 analog, DPP-4 inhibitors and amylin replacement as adjunct therapy | ||
| Review method of action for each therapy | ||
| Potential patients who will benefit from new therapies | ||
| Case presentation utilizing adjunct therapies | ||
Price:
You have two ways to participate.
| 1. | As an individual for the price of $30 per webinar. |
| 2. | As a site for the price of $ 125 per webinar. A site is defined as one computer connection and one telephone connection. The number of professionals awarded continuing education per site is unlimited. Sites and individuals that reserve all four (4) webinars receive a 10% discount for the series |
Refunds:
A refund will be granted, minus a $25 processing fee, if request is received in writing via fax (303/320-1550) at least 48 hours prior to the program.
System Requirements:
- Operating System: Windows 98 to present, Macintosh OSX, Linux.
- Browser: Java-enabled Internet Explorer (IE) 5.1+, Firefox 1.0+, Opera 7.52+, Mozilla 1.71+, and Netscape 7.2+. Please disable any software that prevents pop-up windows from occurring during the conference.
- Hardware: Minimum of 28.8Kbps Internet access.
- Screen resolution: 1024x768 or higher resolution preferred; 800x600 minimum.
- Additional: If listening over the web, you will need either speakers or headphones; a cable modem, DSL, ISDN, or equivalent broadband needed to receive audio/video streaming (128K minimum); Macromedia Flash 6.0+ or Windows Media Player (WMP) 6.4+; Java 1.5.0+ version.
Registration:
- Register Form Online and submit
- Mail: download the registration form and mail
- Fax: download the registration form and fax (303/320-1550)
- Phone: call 800/659-5808